Look for:

Our offer for

Research Detail

2023/01/09 / Erste Group Research

European equities on the upswing


Rating changes: AstraZeneca, Siemens, Albemarle Corp, Intuit, United Parcel Service

The European stock market is currently benefiting above all from lower energy prices and its low valuation. The sharp drop in the price of natural gas is very beneficial, especially for the European industrial sector. The valuation of European equities is also favoring the current rise in the indices. According to P/E ratio 2023e, which is 12.9x, European stocks are valued far below their historical average.

For Q4 2022, European equities are expected to increase earnings by +15% y/y. Sales should increase by +7% (y/y). In the following quarters, earnings growth will then decline (1Q 2023e: +5%). From 2Q 2023, it will remain negative for 2 quarters before profit growth is achieved again.


PDF Download Download PDF (5.3MB)

General information

AuthorErste Group Research
Date2023/01/09
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, United States
Currency in focusEuro, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 5 of 6
Name  ISIN# Erste Group products
SanofiFR00001205780
SAPDE00071646004
Schneider Electric FR00001219720
ServiceNowUS81762P10210
ShellGB00B03MLX290
SiemensDE00072361010
Southern CoUS84258710710
StarbucksUS85524410940
T-Mobile USUS87259010400
Taiwan SemiconductorTW00023300080
TencentKYG8757216340
Tesla US88160R10140
Thermo Fisher ScientificUS88355610230
Tokyo ElectronJP35714000050
TotalEnergiesFR00001202710
Toyota MotorJP36334000010
UBSCH02447675850
UniCreditIT00052393600
UnileverGB00B10RZP780
UnitedHealth GroupUS91324P10210
ValeBRVALEACNOR00
VerizonUS92343V10440
Vertex Pharmaceuticals US92532F10030
Vestas Wind SystemsDK00102686060
Vinci FR00001254860



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer